Insulin resistance underlying type-2 diabetes (T2DM) superimposed on obesity is known to elevate plasma levels of inflammatory markers such as IL-6, TNFα. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.